Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSavills Regulatory News (SVS)

Share Price Information for Savills (SVS)

Share Price is delayed by 15 minutes
Get Live Data
812.00    4.00 (0.50%)
Bid:
811.00
Ask:
813.00
Spread: 2.00 (0.247%)
Market Cap: £1.13b
SVS Live PriceLast checked at - London Stock Exchange

Intraday Savills Share Chart

AGM Statement

8 May 2019 10:04

RNS Number : 3697Y
Savills PLC
08 May 2019
 

 

8 May 2019

SAVILLS PLC

("Savills" or "the Company")

AGM Statement

 

Savills plc, the international real estate advisor, is today holding its Annual General Meeting (AGM) at 12 noon, 33 Margaret Street, London, W1G 0JD, and provides the following AGM statement.

 

During the year to date the Group has traded in line with our expectations. Globally, our transaction businesses have continued to maintain strong market shares although, as anticipated, volumes in certain markets have been subdued as a result of political and economic uncertainty. Our Consultancy, Property Management and Investment Management businesses have continued to perform well.

 

In the UK, trading has been resilient despite increased political uncertainty. In our Residential Transaction business there has been a healthy increase in indicators which are normally a precursor to increased market activity. Of particular note is strong double digit increases in new buyers registered and a year-on-year increase in revenue in the prime Central London market. The Commercial Transaction business is also proving resilient, particularly in Central London, however, volumes across the UK have declined and development activity is relatively subdued.

 

In Asia Pacific, Savills has had a good start to the year, with Hong Kong, Mainland China, Singapore and Vietnam showing year-on-year revenue growth.

 

In North America, the business has successfully rebranded to Savills and continued its strong revenue performance from Q4 2018 through the period, with corporates generally active in relatively benign market conditions. The New York, Washington and Californian markets have proved particularly active to date.

 

In Continental Europe and the Middle East, we have traded in line with our expectations, with good year-on-year revenue growth in Ireland, France, the Netherlands and the Czech Republic. In Sweden, the new Capital markets and leadership team have started well accumulating a strong pipeline of potential transaction activity for the second half of the year.

 

Savills Investment Management has performed as expected. As previously announced, we successfully concluded the search for a new CEO for Savills Investment Management , with Alex Jeffrey due to join the firm later in the year.

 

Whilst the year has started as expected, the first few months typically represent a relatively modest proportion of the expected outturn for the full year. In the UK market, there remains significant investor demand but commercial transaction activity in the next few months may continue to be overshadowed by the prolonged uncertainty over Brexit, the exact impact of which is difficult to determine at present. We do, however, expect some strengthening of activity in certain overseas markets and, despite a greater weighting towards H2 than last year, we continue to anticipate overall performance for 2019 to be in line with our expectations.

 

For further information, contact:

 

Savills 020 7409 8934

Mark Ridley, Group Chief Executive

Simon Shaw, Group Chief Financial Officer

 

Tulchan Communications 020 7353 4200

David Allchurch

Elizabeth Snow

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
AGMLIFIAELITIIA
Date   Source Headline
1st Oct 202511:00 amRNSTotal Voting Rights
29th Sep 202512:09 pmRNSDirector Declaration
25th Sep 20257:00 amRNSDirectorship Change
11th Sep 202512:38 pmRNSDirector/PDMR Shareholding
5th Sep 20252:00 pmRNSAdditional Listing
14th Aug 20257:00 amRNSHalf-year Report
12th Aug 20252:39 pmRNSDirector/PDMR Shareholding
1st Aug 20253:41 pmRNSHolding(s) in Company
21st Jul 20252:03 pmRNSBlock listing Interim Review
16th Jul 20251:44 pmRNSHolding(s) in Company
15th Jul 20254:20 pmRNSHolding(s) in Company
14th Jul 20251:14 pmRNSHolding(s) in Company
14th Jul 202510:18 amRNSDirector/PDMR Shareholding
1st Jul 20257:00 amRNSTotal Voting Rights
30th Jun 20255:20 pmRNSDirector/PDMR Shareholding
23rd Jun 20252:45 pmRNSHolding(s) in Company
20th Jun 20254:00 pmRNSAdditional Listing
12th Jun 20258:15 amRNSDirector/PDMR Shareholding
12th Jun 20258:10 amRNSDirector/PDMR Shareholding
10th Jun 20255:57 pmRNSDirector/PDMR Shareholding
4th Jun 202512:12 pmRNSHolding(s) in Company
2nd Jun 20253:05 pmRNSHolding(s) in Company
2nd Jun 20258:58 amRNSHolding(s) in Company
22nd May 20255:31 pmRNSHolding(s) in Company
15th May 20254:06 pmRNSHolding(s) in Company
14th May 20252:38 pmRNSResult of AGM
14th May 20257:00 amRNSAGM Statement
13th May 20254:01 pmRNSDirector/PDMR Shareholding
29th Apr 20257:00 amRNSSavills Announces Succession Plan
7th Apr 20254:18 pmRNSAnnual Report and AGM Notice
1st Apr 202511:00 amRNSTotal Voting Rights
24th Mar 20252:18 pmRNSHolding(s) in Company
21st Mar 20253:00 pmRNSAdditional Listing
20th Mar 20259:21 amRNSDirector/PDMR Shareholding
18th Mar 20252:27 pmRNSHolding(s) in Company
13th Mar 20257:00 amRNSFinal Results
12th Mar 202511:00 amRNSDirector/PDMR Shareholding
17th Feb 20254:43 pmRNSBlock listing Interim Review
12th Feb 202511:10 amRNSDirector/PDMR Shareholding
11th Feb 20252:32 pmRNSHolding(s) in Company
7th Feb 20253:51 pmRNSHolding(s) in Company
3rd Feb 202511:00 amRNSTotal Voting Rights
29th Jan 20252:28 pmRNSHolding(s) in Company
28th Jan 20253:47 pmRNSHolding(s) in Company
22nd Jan 202511:47 amRNSBlock listing Interim Review
16th Jan 20257:00 amRNSYear End Trading Update
13th Jan 20252:35 pmRNSDirector/PDMR Shareholding
2nd Jan 20253:00 pmRNSTotal Voting Rights
16th Dec 20244:03 pmRNSHolding(s) in Company
12th Dec 202411:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.